Window to Japan
Within the program which runs from 2014 to 2018 and will be publicly funded by about 10 billion Yen (~ 70 million €), it will be attempted to combine knowledge on micro RNA tumor markers from several 100.000 patients stored in BioBank, and the highly sensitive DNA chip which Toray has developed, to build a […]
According to Nikkei Biotech Magazine, the IT company Fujisoft has established a subsidiary which will soon enter the market of tissue engineering with implanted regenerated cartilage Nikkei Biotech news release, August 20, 2014
In collaboration with Prof Shinichi KITAMURA of Osaka Prefectural University, it was shown that this effect is due to an exopolysaccharide produced by this strain. In a mouse model for atopic dermatitis, faster healing or prevention were obtained. Fujicco news release, August 20, 2014